Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1diabetes

被引：0
|
作者：
Devendra, D
Paronen, J
Miao, DM
Liu, E
Eisenbarth, GS
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A297 / A297
页数：1
相关论文
共 50 条
  • [1] Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes
    Devendra, D
    Paronen, J
    Moriyama, H
    Miao, D
    Eisenbarth, GS
    Liu, E
    [J]. JOURNAL OF AUTOIMMUNITY, 2004, 23 (01) : 17 - 26
  • [2] Immune Responses to Insulin B:9-23Related Peptides Were Observed in Fulminant Type 1 Diabetes
    Oikawa, Yoichi
    Satomura, Atsushi
    Haisa, Akifumi
    Suzuki, Seiya
    Shimada, Akira
    [J]. DIABETES, 2020, 69
  • [3] Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes
    Wenzlau, Janet M. M.
    DiLisio, James E. E.
    Barbour, Gene
    Dang, Mylinh
    Hohenstein, Anita C. C.
    Nakayama, Maki
    Delong, Thomas
    Baker, Rocky L. L.
    Haskins, Kathryn
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [4] Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B(9-23) epitope
    Alleva, DG
    Maki, RA
    Putnam, AL
    Robinson, JM
    Kipnes, MS
    Dandona, P
    Marks, JB
    Simmons, DL
    Greenbaum, CJ
    Jimenez, RG
    Conlon, PJ
    Gottlieb, PA
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2006, 63 (01) : 59 - 69
  • [5] Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B(9-23) epitope.
    Alleva, DG
    Maki, RA
    Putnam, AL
    Kipnes, MS
    Dandona, R
    Marks, JB
    Simmons, DL
    Greenbaum, CJ
    Jimenez, RJ
    Conlon, PJ
    Gottlieb, PA
    [J]. CLINICAL IMMUNOLOGY, 2005, 115 : S137 - S137
  • [6] GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat
    Bieg, S
    Hanlon, C
    Hampe, CS
    Benjamin, D
    Mahoney, CP
    [J]. AUTOIMMUNITY, 1999, 31 (01) : 15 - 24
  • [7] Induction of insulin autoantibodies and protection from diabetes with subcutaneous insulin B:9-23 peptide without adjuvant
    Liu, E
    Abiru, N
    Moriyama, H
    Miao, DM
    Eisenbarth, GS
    [J]. IMMUNOLOGY OF DIABETES: AUTOIMMUNE MECHANISMS AND THE PREVENTION AND CURE OF TYPE 1 DIABETES, 2002, 958 : 224 - 227
  • [8] A monoclonal antibody with broad specificity for the ligands of insulin B:9-23 reactive T cells prevents spontaneous type 1 diabetes in mice
    Cepeda, Joseph Ray
    Sekhar, Nitin S.
    Han, Junying
    Xiong, Wei
    Zhang, Ningyan
    Yu, Liping
    Dai, Shaodong
    Davidson, Howard W.
    Kappler, John W.
    An, Zhiqiang
    Zhang, Li
    [J]. MABS, 2020, 12 (01)
  • [9] Spontaneous animal models for insulin-dependent diabetes (type 1 diabetes).
    Sai, P
    Gouin, E
    [J]. VETERINARY RESEARCH, 1997, 28 (03) : 223 - 229
  • [10] Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9-23-related peptides in subtypes of type 1 diabetes
    Oikawa, Yoithi
    Sakamoto, Kumiko
    Satomura, Atsushi
    Haisa, Akifumi
    Katsuki, Takeshi
    Hattori, Yutaka
    Inoue, Ikuo
    Noda, Mitsuhiko
    Shimada, Akira
    [J]. CLINICAL IMMUNOLOGY, 2019, 208
12345